InvestorsHub Logo
Followers 50
Posts 2326
Boards Moderated 0
Alias Born 06/26/2017

Re: MR Bucks post# 376179

Monday, 09/27/2021 1:15:33 PM

Monday, September 27, 2021 1:15:33 PM

Post# of 403060
Here is what I like (in bold) about the link you posted. It seems to me that some posters on this board have zero clue what Compassionate Use means from the FDA's standpoint.

Sometimes called “compassionate use”, expanded access is a potential pathway for a patient with an immediately life-threatening condition or serious disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.

Doctor talking to patient
Expanded access may be appropriate when all the following apply:

Patient has a serious disease or condition, or whose life is immediately threatened by their disease or condition.
There is no comparable or satisfactory alternative therapy to diagnose, monitor, or treat the disease or condition.
Patient enrollment in a clinical trial is not possible.
Potential patient benefit justifies the potential risks of treatment.
Providing the investigational medical product will not interfere with investigational trials that could support a medical product’s development or marketing approval for the treatment indication.

$IPIX$
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News